Cargando…
Estimating cost-effectiveness associated with all-oral regimen for chronic hepatitis C in China
BACKGROUND: All-oral regimens are associated with higher effectiveness and shorter treatment duration for chronic hepatitis C. Given its superior effect and enormous patients in China, clinicians or patients may be compelled to consider delaying treatment for all-oral regimen. OBJECTIVE: To estimate...
Autores principales: | Chen, Hai, Chen, Lijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381915/ https://www.ncbi.nlm.nih.gov/pubmed/28380022 http://dx.doi.org/10.1371/journal.pone.0175189 |
Ejemplares similares
-
Treatment of Hepatitis C in HIV-Infected Patients: Moving Towards an Era of All Oral Regimens
por: Chen, Ting-Yi, et al.
Publicado: (2015) -
Cost–Utility of All-Oral Direct-Acting Antiviral Regimens for the Treatment of Genotype 1 Chronic Hepatitis C Virus-Infected Patients in Hong Kong
por: Yuen, Man-Fung, et al.
Publicado: (2020) -
Cost-Effectiveness Analysis of Pan-Genotypic Sofosbuvir-Based Regimens for Treatment of Chronic Hepatitis C Genotype 1 Infection in China
por: Zhou, Hui Jun, et al.
Publicado: (2021) -
Cost-Effectiveness of All-Oral Regimens for the Treatment of Multidrug-Resistant Tuberculosis in Korea: Comparison With Conventional Injectable-Containing Regimens
por: Park, Hae-Young, et al.
Publicado: (2023) -
Successful Treatment of Mixed Hepatitis C Genotypes in a Cirrhotic Patient With an All-Oral, Interferon-Free Regimen
por: Ahmed Sakr, Ayman, et al.
Publicado: (2017)